神経筋接合部とA型ボツリヌス毒素製剤

DOI DOI Web Site Web Site 被引用文献1件 参考文献7件

書誌事項

タイトル別名
  • The Neuromuscular Junction and Botulinum Toxin Type A
  • シンケイキン セツゴウブ ト Aガタ ボツリヌス ドクソ セイザイ

この論文をさがす

抄録

Injecting botulinum toxin type A (BTX-A) into spastic muscles is a recent alternative for treating conditions such as stroke, spinal cord injury, and cerebral palsy. BTX-A injection blocks acetylcholine release at the neuromuscular junction (NMJ) in the muscles. Therefore, BTX-A must be injected near the NMJ. In this paper, the anatomical, histochemical, and electrophysiological studies to determine the location of NMJs in the extremities are reviewed. Further, methylene blue vital staining as a method to identify the intramuscular nerve fibers and NMJs in the muscle and propose a so-called “mid portion of muscle fibers” along with the NMJ map of the upper and lower limbs are discussed.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (7)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ